ClinicalTrials.Veeva

Menu

Moving Forward: A Weight Loss Intervention for African-American Breast Cancer Survivors

Medical College of Wisconsin logo

Medical College of Wisconsin

Status

Completed

Conditions

Breast Cancer

Treatments

Behavioral: MF-WLP
Behavioral: SG-WLP

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02482506
BRE-WL4AA

Details and patient eligibility

About

This is a randomized intervention study to examine the effects of the Moving Forward Guided Weigh Loss Intervention compared to a self-guided weight loss program on BMI and behavioral, biological, and psychosocial outcomes in overweight and obese African American women diagnosed with Stage I, II, or III breast cancer.

Full description

This is a randomized study with 300 African American (AA) breast cancer survivors to be conducted in Chicago Park District (CPD) facilities. The study will be based in six predominantly AA communities in Chicago (Roseland, Pullman, Englewood, Chatham, Austin, South Shore, Woodlawn, Calumet Heights, North Lawndale and Grand Crossing). These communities have at least one CPD fitness center, have populations that are at least 90% or more AA and have similar socioeconomic statuses. Fifty AA breast cancer survivors will be recruited from each community (25 treatment/ 25 control).

The Moving Forward intervention integrates concepts from Social Cognitive Theory (SCT) and the Socio-Ecological Model (SEM) to promote independent behavior change. SCT suggests that behavior can be explained by the dynamic interaction between behavior, personal factors (e.g., self-efficacy), and the environment (e.g, social support). Self-efficacy is a person's confidence in performing a particular behavior and overcoming barriers to that behavior. A number of studies have supported the mediating role of self-efficacy in making independent health behavior changes.

The overall goal of Moving Forward is to make independent changes in health behaviors to promote a healthy weight. The weight loss goal will be consistent with the recommendations of an expert panel at National Institutes of Health (NIH). Dietary goals aimed at producing weight loss, decreasing BC recurrence risk, and improving overall health include 1) a decrease in daily caloric intake (based on weight in pounds X 12 kcal/day with 500-750 calories subtracted to create an energy deficit); 2) a decrease in dietary fat consumption to 20% of total calories; 3) an increase in fruit and vegetable consumption to 7 daily servings; and 4) an increase in fiber to 25 grams per day. For exercise, participants will gradually increase their activity to a minimum of 180 minutes per week at 55-65% maximal heart rate.

Enrollment

240 patients

Sex

Female

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Self-identification as Black or African American (including individuals who are bi-racial but identify themselves as Black or AA)
  • Female
  • Stage I, II, and III invasive breast carcinoma
  • Treatment (surgery, chemotherapy and/or radiation) completed at least 6 months prior to recruitment (ongoing treatment with tamoxifen or AIs is acceptable)
  • Age 18 or above at time of diagnosis
  • BMI at least 25 km/m2
  • Physically able to participate in a moderate physical activity program as assessed by a screening questionnaire and PCP approval.
  • Agreeable to random assignment and data collection including blood draw.
  • Able to attend twic weekly classes for 6 months.

Exclusion criteria

  • Plans to move from the community during the study
  • Medical condition limiting adherence as assessed by PCP
  • History of significant mental illness
  • Currently pregnant, less than 3 months post-partum, or pregnancy anticipated during the study..
  • Current/planned use of an FDA-approved or over the counter weight loss medication.
  • Participation in another structured weight loss program

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

240 participants in 2 patient groups

SG-WLP
Other group
Description:
Self-guided weight loss program
Treatment:
Behavioral: SG-WLP
MF-WLP
Active Comparator group
Description:
Moving Forward Weight Loss Program
Treatment:
Behavioral: MF-WLP

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems